ChiCTR1800019111: An open-label, single-dose and single- plus multiple-dose study to assess the pharmacokinetic profile of FLUTIFORM pMDI 50/5 μg (100/10 μg total dose), 125/5 μg (250/10 μg total dose), and 250/10 μg (500/20 μg total dose) in healthy Chinese subjects |
|
|
| Recruiting | 1 | 36 | | FLUTIFORM pMDI single-dose administration (50/5 μg, 125/5 μg, and 250/10 μg) and multiple-dose administration (250/10 μg) | West China Hospital, Sichuan University; Mundipharma (China) Pharmaceutical Co. Ltd, Mundipharma (China) Pharmaceutical Co. Ltd | Asthma | | | | |
